MedTrade Products

What MedTrade Products does

MedTrade Products Limited, trading as CELOX Medical, is a UK-based medical technology company founded in 1999 that develops, manufactures, and distributes patented hemostatic and wound care products. The company's core technology platform is CELOX, a proprietary hemostatic agent used to control life-threatening bleeding, which underpins a portfolio that includes pre-hospital products (CELOX Rapid, CELOX-A, CELOX Granules, CELOX Gauze, MAG-TQ tourniquet, FOXSEAL and FOXSEAL Vented chest seals, Silvapro for burns), hospital products (AVARUS IV, Multiflex, Border Foam, and Post Op advanced wound care dressings), and the CELOX PPH uterine haemostatic tamponade for postpartum hemorrhage. The company serves military, tactical and security forces, emergency medical services, hospitals, long-term care facilities, workplaces, and personal use consumers across global markets.

The company operates a 51-100 employee organization from its Crewe, UK headquarters, with a regional office in New York (OMNI-STAT Medical) supporting North American distribution. Revenue is generated through direct enterprise sales to hospitals, military, and emergency services, supplemented by a network of regional distributors; a notable partnership with Swiss firm Laubscher and Co AG (March 2023) handles CELOX PPH distribution in Switzerland. Pricing is not publicly disclosed, and the company uses a consultative contact-based sales model typical of medical device makers serving clinical and government buyers.

In February 2025 the company rebranded from MedTrade Products to CELOX Medical to align its corporate identity with its flagship product brand. The company is privately held, with no disclosed parent entity, and reported leadership includes CEO Russ Mably, founder/chairman Craig Hardy, and CFO Stephen Collins. A 2019 growth capital round of approximately $33.7M from Tikehau Capital is the only disclosed institutional funding event. The company has not publicly disclosed revenue figures.

Name

MedTrade Products

Legal name

Medtrade Products Limited

Website

https://medtrade.co.uk

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

MedTrade Products (trading as CELOX Medical) is a UK-based medical technology company founded in 1999 that develops and manufactures patented CELOX hemostatic products and wound care devices for military, EMS, hospital, and consumer use across global markets.

Ownership category

akta.pro rank

Product category

Hemostatic and Advanced Wound Care Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care) (CRADAMAB)

akta.pro secondary industry

Postpartum Feminine Care (CRABAIAL)

Keywords

• Hemostatic wound care
• Hemorrhage control devices
• Medical gauze dressings
• Tactical medical supplies
• Advanced wound dressings

Headquarters

HQ city

Crewe

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of patented hemostatic products and medical devices for hemorrhage control, wound care, burn treatment, and related applications. Products are sold through direct sales and channel partners to healthcare providers, military, and emergency services.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

MedTrade Products (trading as CELOX Medical) develops and manufactures patented hemostatic and wound care medical devices built on its proprietary CELOX technology. The portfolio spans pre-hospital hemorrhage control (CELOX Rapid, CELOX-A, CELOX Granules, CELOX Gauze, MAG-TQ tourniquet, FOXSEAL chest seals, Silvapro burn dressings) and hospital advanced wound care (AVARUS IV, Multiflex, Border Foam, and Post Op dressings), plus the CELOX PPH uterine tamponade for postpartum hemorrhage. Products are sold to military, emergency medical services, hospitals, workplaces, long-term care facilities, and individual consumers globally.

Product overview

CELOX Medical (trading name of Medtrade Products Ltd) is a global med-tech company offering a unified portfolio of patented, evidence-based medical technologies focused on hemorrhage control and wound care. The product portfolio is organized into two main segments: Pre-Hospital (including CELOX™ Rapid, CELOX™-A, CELOX™ Granules, CELOX™ Gauze, MAG-TQ™, FOXSEAL™, FOXSEAL™ Vented, and Silvapro for hemorrhage control, respiration management, and burn treatment) and Hospital (including AVARUS™ IV, AVARUS™ Multiflex, AVARUS™ Border Foam, and AVARUS™ Post Op for advanced wound care). The portfolio also includes specialized solutions like the CELOX PPH uterine haemostatic tamponade for postpartum hemorrhage. All products leverage patented CELOX™ technology for hemostatic efficacy.

Differentiator

Problem solved

Functional benefit

Products and services

• CELOX Rapid Rapid-acting hemostatic agent for hemorrhage control in pre-hospital and emergency settings, designed for military, tactical, and EMS use.
• CELOX-A Hemostatic dressing designed for hemorrhage control applications in pre-hospital and emergency settings.
• CELOX Granules Granular hemostatic agent for controlling severe bleeding in emergency situations.
• CELOX Gauze Hemostatic gauze dressing for wound packing and bleeding control in pre-hospital and emergency settings.
• MAG-TQ Tourniquet device for hemorrhage control in tactical and pre-hospital settings.
• FOXSEAL Chest seal device for managing sucking chest wounds and respiration emergencies.
• FOXSEAL Vented Vented chest seal variant for chest trauma management with improved venting capability.
• Silvapro Silver-based burn treatment product for wound care management.
• AVARUS IV Advanced IV securement dressing with chlorhexidine gluconate (CHG) for infection prevention.
• AVARUS Multiflex Multi-use advanced wound care dressing offering flexible coverage for various wound types.
• AVARUS Border Foam Foam wound dressing with adhesive border for securement and exudate management.
• AVARUS Post Op Post-operative wound dressing designed for post-surgical incision care.
• CELOX PPH Uterine Haemostatic Tamponade Solution Specialized hemostatic tamponade device for addressing postpartum hemorrhage in maternity care settings, introduced in partnership with Laubscher and Co AG for the Swiss market.

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Laubscher and Co AGcoreChannel Partner/ Reseller/ Distributor · 1 March 2023In March 2023, UK-based Medtrade Products (now CELOX Medical) partnered with Swiss company Laubscher and Co AG to introduce the CELOX PPH uterine haemostatic tamponade solution for addressing postpartum hemorrhage in Switzerland. This partnership enabled distribution of the CELOX PPH product in the Swiss market.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Z-Medica (QuikClot): Z-Medica is the closest direct competitor to MedTrade/CELOX, selling the QuikClot line of hemostatic gauze and dressings used by militaries, EMS, and hospitals worldwide. Both companies compete head-to-head on chitosan- and kaolin-based hemorrhage control technology for tactical and pre-hospital use.
• Advanced Medical Solutions: Advanced Medical Solutions is a UK-listed wound care and surgical med-tech company with overlapping hemostatic, wound closure, and advanced wound dressing franchises. Comparable business model (B2B med-device manufacturer selling to hospitals and OEMs globally), similar UK origin, and directly competing product categories make it the most analogous public peer for MedTrade/CELOX.
• HemCon Medical Technologies: HemCon develops chitosan-based hemostatic dressings and hemorrhage control products for military, EMS, and hospital buyers, directly overlapping CELOX's core offering. Both compete in the same chitosan hemostat technology category and similar procurement channels.

Broad incumbents

• Baxter International: Baxter markets Floseal and other surgical hemostatic agents used in operating rooms and competes with CELOX in intraoperative bleeding control. As a large diversified medical products incumbent, Baxter competes on broader surgical portfolios rather than specializing in CELOX's pre-hospital/tactical niche.
• Teleflex: Teleflex offers hemostatic products and a broad tactical/EMS portfolio including tourniquets and emergency airway devices that overlap with CELOX and MAG-TQ. Teleflex competes as a broader incumbent in the same military, EMS, and hospital channels.
• Smith & Nephew: Smith & Nephew is a global leader in advanced wound management, with dressings, negative pressure wound therapy, and surgical products that overlap with the AVARUS advanced wound care line. As a large incumbent, it competes in hospital and long-term care channels where CELOX also sells.
• Mölnlycke Health Care: Mölnlycke is a major wound care and surgical solutions provider (Mepilex, Mepitel, Avance negative pressure) whose advanced wound dressings and burn care products overlap with the AVARUS and Silvapro franchises. It competes broadly in hospital and long-term care settings alongside CELOX.
• ConvaTec: ConvaTec is a global wound care, ostomy, and continence care company whose advanced wound dressings portfolio (AQUACEL, Foam dressings) competes with the AVARUS line in hospitals and long-term care facilities. It is a comparable broad incumbent in wound management.
• 3M Health Care (Solventum): 3M Health Care (now Solventum) supplies a wide range of wound dressings, surgical tapes, and skin integrity products used in hospitals, EMS, and long-term care, overlapping with the AVARUS, Silvapro, and FOXSEAL product lines. It is a broad incumbent rather than a niche hemostat specialist.

Emerging players

• BioCer Entwicklungs-GmbH: BioCer Entwicklungs is a smaller German med-tech company active in hemostatic and bone healing biomaterials, partially overlapping with CELOX's chitosan-based technology. It represents an emerging/specialist peer with thematic rather than direct commercial overlap.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/CeloxMedical
• YouTubeyoutube.com/user/CeloxMedical
• Facebookfacebook.com/pages/Celox/117577136964
• LinkedInlinkedin.com/company/medtrade-products-limited
• Instagraminstagram.com/celoxmedical

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedTrade Products